Literature DB >> 885993

The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine.

W M Wiersinga, J L Touber.   

Abstract

The effect of the beta-adrenoceptor blocking agent propranolol on plasma levels of thyroxine and triiodothyronine was studied in eleven hyperthyroid patients and in six hypothyroid patients on L-thyroxine substitution therapy. In all patients a decrease in plasma-triiodothyronine was found. The per cent decrease of plasma-triiodothyronine was the same in both groups. Plasma levels of thyroxine and thyrotropin increased in the hypothyroid patients, but remained constant in the hyperthyroid subjects. The decrease in plasma-triiodothyronine during propranolol medication is most likely caused by an inhibition of the peripheral conversion of thyroxine into triiodothyronine.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 885993     DOI: 10.1210/jcem-45-2-293

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Observations on the factors that control the generation of triiodothyronine from thyroxine in rat liver and the nature of the defect induced by fasting.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1979-06       Impact factor: 14.808

4.  [Basedow-Graves' disease: operative treatment (author's transl)].

Authors:  H D Röher
Journal:  Langenbecks Arch Chir       Date:  1978-11

Review 5.  Euthyroid hyperthyroxinemia.

Authors:  R Rajatanavin; L E Braverman
Journal:  J Endocrinol Invest       Date:  1983-12       Impact factor: 4.256

6.  The influence of fasting, diabetes, and several pharmacological agents on the pathways of thyroxine metabolism in rat liver.

Authors:  A Balsam; S H Ingbar
Journal:  J Clin Invest       Date:  1978-08       Impact factor: 14.808

7.  Coma secondary to apathetic thyrotoxicosis.

Authors:  O Serri; R M Gagnon; Y Goulet; M Somma
Journal:  Can Med Assoc J       Date:  1978-09-23       Impact factor: 8.262

8.  A study of long acting propranolol in the early management of hyperthyroidism.

Authors:  G R Jones; J H Lazarus; D Wynford-Thomas
Journal:  Br J Clin Pharmacol       Date:  1981-12       Impact factor: 4.335

9.  Effects and plasma levels of propranolol and metoprolol in hyperthyroid patients.

Authors:  O R Nilsson; A Melander; L Tegler
Journal:  Eur J Clin Pharmacol       Date:  1980-10       Impact factor: 2.953

10.  Comparison of propranolol and metoprolol in the management of hyperthyroidism.

Authors:  L E Murchison; J How; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.